What a comprehensive metabolic and hormonal evaluation actually looks for — and why the right starting point matters.

Lean-mass loss is the most documented risk of GLP-1 treatment without structured metabolic care. Here is what the research actually shows — and what serious care does about it.

Insulin, hormones, sleep, and stress physiology move together in perimenopause — which is why the weight loss strategies that worked at 35 stop working.

Lean mass drives your metabolic rate, your insulin sensitivity, and your independence as you age — and the order of weight-loss interventions helps determine whether you keep it as you lose fat.

Hormonal care managed in a silo misses half the picture. Why hormone therapy belongs inside your metabolic plan — not in a separate room.